Inscription Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,000
Closed -$302K 229
2021
Q3
$302K Buy
+3,000
New +$302K 0.09% 166
2021
Q2
Sell
-3,000
Closed -$299K 396
2021
Q1
$299K Buy
+3,000
New +$299K 0.1% 150